Exploring the Potential of Epigenetic Profiling in Drug Development

Attend this CPD Accredited Masterclass to get a better understanding of the application of epigenetic profiling to pharmaceutical development. Appreciating the potential of such techniques could result in brilliant advances in life saving technology.
By: SMi Group Ltd.
 
Aug. 17, 2010 - PRLog -- Join the SMi Group Ltd. and associated pharmaceutical consultancy company OncoLytika Ltd. in Central London on the 7th December 2010 for elaborate information on the issues surrounding and the application of epigenetic profiling.

Epigenetics is the study of the regulation of gene expression through non-sequence based factors. It is what links our primary gene sequencing to our environment allowing for differential gene expression, environmental gene modulation, reversible expression and provision of certain inheritable traits. Therapeutics for cancer, neurodegenerative and infectious diseases based on epigenetic targets are already in development and research is underway to explore the role for epigenetics in cardiovascular, metabolic and other diseases.


FOR A FULL PROGRAMME GUIDE AND AN OPPORTUNITY TO REGISTER ONLINE PLEASE VISIT;

http://www.smi-online.co.uk/2010epigenetics4.asp

SUPPORTING COMPANY

OncoLytika Ltd. is developing an in-house portfolio of therapeutic and imaging products and provides consultancy services to the Pharma and Biotech sectors in the areas of preclinical development and formulation including outsourced project management. Additional activities include due diligence, business planning support including opportunity recognition, market assessment and marketing plan development. www.oncolytika.com  

WORKSHOP LEADER

Mark Eccleston is the Managing Director of OncoLytika Ltd. He has previously worked for ValiRx Plc – an epigenetics based oncology company listed on AIM – and is a director of ValiFinn – a Finnish CRO offering epigenetic profiling services. He has set up several innovative companies in the biotechnology and fast moving consumer goods sector working in project management, preclinical development and business development. He has a PhD in Polymer Chemistry and gained an MBA from the University of Cambridge.

# # #

SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.

SMi Conferences offer you an unrivalled opportunity to network within your area of business and our Workshops and Masterclasses provide an intimate, interactive forum in which to learn about the latest techniques and developments.
End
Source:SMi Group Ltd.
Email:***@smi-online.co.uk
Posted By:***@smi-online.co.uk Email Verified
Zip:SE1 0HS
Tags:Drug Development, CPD, Cancer, Pharmaceutical, Advances, Masterclass, Smi
Industry:Pharmaceuticals, Development, Drug testing
Location:London City - London, Greater - England
Account Email Address Verified     Disclaimer     Report Abuse
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share